About this trial
This study will test the hypothesis that the drugs propranolol and metoprolol will result in greater increases in core body temperature during 3 hours of extreme heat exposure in older adults.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Healthy and free of any significant medical problems
Normal resting electrocardiogram
65+ years of age
Controlled cholesterol of less than 200 mg/dl
Disqualifiers
Known diseases or other chronic conditions requiring regular medical therapy including cancer, diabetes, neurological diseases, uncontrolled hypertension, and uncontrolled hypercholesterolemia
Serious abnormalities detected on routine screening
Taking prescribed medications or over-the-counter medications that have known influences on either cardiac function or sweating
Current smokers, as well as individuals who regularly smoked within the past 3 years
Trial design
Crossover
Treatments tested in this trial
Ambient Heat
Other interventionSubjects will spend 3-hours in a heat chamber at 41°C and 40% humidity.
Treatment groups
6
Treatment groupsSee each treatment group below.
Trial outcomes
Primary outcomes
Internal temperature
The change in internal temperature to the 3-hour heat exposure will be measured.
Whole body sweat rate
Whole body sweat rate will be measured via changes in pre/post nude body mass.
Secondary outcomes
Heart rate
Heart rate will be measured via electrocardiogram.
Arterial blood pressure
Systolic and diastolic arterial blood pressures will be measured via a brachial blood pressure cuff.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.